Back to search

Insight Biotechnology Limited

03093313

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

110 CHANDOS AVENUE, LONDON, N20 9DZ
Incorporated 21/08/1995

Compliance

Last accounts

31/12/2024

total exemption full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 08/08/2025

Due 22/08/2026

On track

Industry

46460
Wholesale of pharmaceutical goods
72110
Research and experimental development on biotechnology

Officers

Mr John Rawlinson

director · Since 16/01/1997

DIRECTOR

BRITISH · ENGLAND · Age 65

Also on 5 other boards

Mrs Alison Rawlinson

secretary · Since 16/02/1998

BRITISH · ENGLAND · Age 64

Also on 11 other boards

Mr Darren Croft

director · Since 18/09/2003

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 57

Mrs Alison Rawlinson

director · Since 01/12/2007

ADMINISTRATOR

BRITISH · ENGLAND · Age 64

Also on 11 other boards

Persons with Significant Control

Mr John Rawlinson

25–50% shares

British · England · Age 65

110, Chandos Avenue, London, N20 9DZ

Notified 08/08/2016

Mrs Alison Rawlinson

25–50% shares

British · England · Age 64

110, Chandos Avenue, London, N20 9DZ

Notified 08/08/2016

Charges0 outstanding

charge
satisfied

NATIONAL WESTMINSTER BANK PLC

Created 07/04/1996Registered 26/04/1996Satisfied 17/03/2014

CompanyRankvs 41+ SIC 46460 peers
88

Financial strength96th percentile among SIC peers · 24/25
Employees94th percentile among SIC peers · 14/15
LiquidityCurrent ratio 11.72× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Rayburn Trading Company Limited
90
2Servier Laboratories Limited
90
3P & A J Cattee (Wholesale) Ltd.
90
4Hameln Pharma Ltd
90
5Day Lewis Medical Limited
90
6Kinetic Enterprises Limited
90
7Morningside Pharmaceuticals Limited
90
8A1 Pharmaceuticals Public Limited Company
90
9Greiner Bio-One Limited
90
10Trafalgar Scientific Limited
90
41Insight Biotechnology Limited
88
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£3.3M

Balance sheet strength

Cash

£2.7M

Cash in the bank

Net Current Assets

£3.3M

Working capital

Current Assets

£3.6M

Current Liabilities

£310k

Fixed Assets

£9k

Debtors

£849k

16avg. employees+1
Prepared with Digita Accounts Production Advanced

EstimatesDerived

YearCurrent RatioImplied Profit
202411.72+£86k
202311.96+£75k
202212.33+£121k
20219.96+£338k
20206.28+£181k
20197.36+£145k
20186.18+£187k
20175.26—

Derived from filed accounts. Not audited figures.